The same neurotransmitter commonly leveraged to relieve symptoms of depression and anxiety also may exacerbate a vexing ...
People who view their depression or anxiety as the result of a chemical imbalance tend to use antidepressants for much longer ...
Commonly used medications for irritable bowel syndrome (IBS), like antidepressants, are linked to a modest absolute increase in mortality risk. | Drug Discovery And Development ...
In September last year, we reported Servier had advanced its emerging neurology pipeline into the clinical trials stage by ...
A large new study links common IBS drugs like loperamide and diphenoxylate to a higher risk of death. Experts say the risk is ...
New study links long-term use of loperamide and diphenoxylate to increased death risk in IBS patients Research analysed ...
A massive, nearly 20-year study tracking over 650,000 Americans with irritable bowel syndrome is raising new questions about the long-term safety of common treatments. Researchers found that some ...
TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime, is the first new FDA-approved treatment for fibromyalgia ...
Research indicates that antidepressant use in IBS is linked to a 35% higher risk of all-cause mortality, highlighting safety issues with long-term treatment.
Researchers say some medications prescribed for irritable bowel syndrome (IBS) may increase a person’s risk of early death.
Pradefovir mesylate, a liver-targeting prodrug of adefovir, proved noninferior to tenofovir disoproxil fumarate (Viread) for ...
A large, long-term study led by Cedars-Sinai Health Sciences University investigators suggests that some medications commonly prescribed to treat irritable bowel syndrome (IBS)—including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results